vTv Therapeutics Inc.
(VTVT)
undefined
undefined%
At close: undefined
15.03
0.00%
After-hours Dec 13, 2024, 03:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | - | 2.02M | 4.00M | 6.41M | 2.76M | 12.43M | 291.00K | 634.00K | 519.00K | 1.55M | 976.00K |
Cost of Revenue | 13.60M | 92.00K | 89.00K | 11.02M | 15.12M | 23.04M | 39.64M | 45.75M | 29.58M | 18.73M | 25.43M |
Gross Profit | -13.60M | 1.93M | 3.92M | -4.60M | -12.36M | -10.60M | -39.35M | -45.11M | -29.07M | -17.18M | -24.46M |
Operating Income | -25.50M | -22.54M | -21.66M | -11.85M | -20.89M | -19.82M | -50.68M | -55.02M | -38.14M | -28.90M | -35.83M |
Interest Income | 472.00K | 352.00K | 1K | 12.00K | 53.00K | 61.00K | 117.00K | 87.00K | - | - | - |
Pretax Income | -25.97M | -24.87M | -17.62M | -12.80M | -21.84M | -23.64M | -53.85M | -55.35M | -41.11M | -36.10M | -48.20M |
Net Income | -20.25M | -25.07M | -17.73M | -8.83M | -21.94M | -7.91M | -16.14M | -16.35M | -27.50M | -36.10M | -48.20M |
Selling & General & Admin | 11.91M | 12.20M | 12.34M | 7.25M | 8.54M | 9.22M | 11.33M | 9.91M | 9.08M | 11.72M | 11.38M |
Research & Development | 13.60M | 12.36M | 13.32M | 11.02M | 15.12M | 23.04M | 39.64M | 45.75M | 29.58M | 18.73M | 25.43M |
Other Expenses | -13.60M | -2.67M | 4.06M | -270.00K | 828.00K | -592.00K | -190.00K | -22.00K | -2.96M | -1.13M | -534.00K |
Operating Expenses | 11.91M | 24.56M | 25.67M | 18.27M | 23.66M | 32.26M | 50.97M | 55.65M | 38.66M | 30.45M | 36.81M |
Interest Expense | 13.00K | 15.00K | 12.00K | 692.00K | 1.83M | 3.29M | 3.09M | 398.00K | 1.74M | 6.01M | 11.82M |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 25.50M | 24.56M | 25.67M | 18.27M | 23.66M | 32.26M | 50.97M | 55.65M | 38.66M | 30.45M | 36.81M |
Income Tax | - | 200.00K | 115.00K | -3.98M | 100.00K | 200.00K | 800.00K | -39.00M | -14.11M | 4.88M | 11.29M |
Shares Outstanding (Basic) | 2.08M | 1.92M | 1.57M | 1.18M | 757.30K | 311.23K | 242.33K | 238.64K | 206.91K | 207.63K | 205.49K |
Shares Outstanding (Diluted) | 2.08M | 1.92M | 1.57M | 1.18M | 757.30K | 311.23K | 242.33K | 238.64K | 206.91K | 207.63K | 205.49K |
EPS (Basic) | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 | -234.57 |
EPS (Diluted) | -9.71 | -13.06 | -11.32 | -7.49 | -28.97 | -25.42 | -66.62 | -68.52 | -132.9 | -173.87 | -234.57 |
EBITDA | -25.41M | -24.77M | -17.52M | -12.02M | -19.97M | -20.14M | -50.56M | -54.69M | -38.87M | -29.23M | -35.30M |
Depreciation & Amortization | 90.00K | 92.00K | 89.00K | 94.00K | 39.00K | 218.00K | 197.00K | 265.00K | 501.00K | 864.00K | 1.09M |